ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc (VNDA)

4.62
0.14
(3.12%)
At close: April 26 4:00PM
4.5199
0.0399
( 0.89% )
After Hours: 7:05PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.5199
Bid
4.60
Ask
4.63
Volume
821,939
4.45 Day's Range 4.625
3.295 52 Week Range 7.00
Market Cap
Previous Close
4.48
Open
4.57
Last Trade Time
17:46:57
Financial Volume
$ 3,758,600
VWAP
4.5728
Average Volume (3m)
2,446,800
Shares Outstanding
57,537,499
Dividend Yield
-
PE Ratio
105.73
Earnings Per Share (EPS)
0.04
Revenue
192.64M
Net Profit
2.51M

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder... Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Vanda Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VNDA. The last closing price for Vanda Pharmaceuticals was $4.48. Over the last year, Vanda Pharmaceuticals shares have traded in a share price range of $ 3.295 to $ 7.00.

Vanda Pharmaceuticals currently has 57,537,499 shares outstanding. The market capitalization of Vanda Pharmaceuticals is $265.25 million. Vanda Pharmaceuticals has a price to earnings ratio (PE ratio) of 105.73.

VNDA Latest News

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious...

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation PR Newswire WASHINGTON, April 22, 2024 WASHINGTON, April 22, 2024 /PRNewswire/ -- Vanda...

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan PR Newswire WASHINGTON, April 17, 2024 WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the...

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak PR Newswire WASHINGTON, April 17, 2024 Board Determined Unsolicited Takeover Proposals Significantly...

Biotech Catches Major Premarket Bid Following FDA Approval

A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment To read the full...

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder PR Newswire WASHINGTON, April 2, 2024 Fanapt® Treatment is Now Available to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4401-8.872983870974.965.34.4316608564.78533429CS
40.28996.853427895984.236.033.8754870124.98318031CS
120.829922.49051490513.696.033.4624468004.74309162CS
260.23995.605140186924.286.033.29516357294.47870049CS
52-1.7301-27.68166.2573.29512679254.76745825CS
156-12.5801-73.567836257317.121.86273.2957566058.03182813CS
260-12.1001-72.804452466916.6221.86273.2956945079.86379919CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FLJFLJ Group Limited
$ 0.69
(25.45%)
1.32M
SBETSharpLink Gaming Inc
$ 1.17
(12.49%)
2.43k
BRFHBarfresh Food Group Inc
$ 1.56
(10.64%)
18.36k
LINKInterlink Electronics Inc
$ 6.11
(9.89%)
208
PEVPhoenix Motor Inc
$ 0.65
(9.61%)
900
CLVRClever Leaves Holdings Inc
$ 1.40
(-65.94%)
144.93k
FCUVFocus Universal Inc
$ 0.2851
(-11.54%)
249.87k
FFIEFaraday Future Intelligent Electric Inc
$ 0.0425
(-9.57%)
6.21M
GNTAGenenta Science SPA
$ 2.35
(-9.27%)
3.03k
CACOCaravelle International Group
$ 0.9079
(-9.21%)
94.38k
IVPInspire Veterinary Partners Inc
$ 0.043
(-2.27%)
13.22M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0425
(-9.57%)
6.21M
PEGYPineapple Energy Inc
$ 0.064
(2.24%)
4.2M
BRSHBruush Oral Care Inc
$ 0.0609
(3.22%)
3.6M
SOFISoFi Technologies Inc
$ 8.08
(2.67%)
3.24M

VNDA Discussion

View Posts
Tiger Money Tiger Money 1 week ago
Agreed. This could double quickly
👍️0
philaya philaya 1 week ago
got this today...
very good trades.
👍️0
harry crumb harry crumb 1 week ago
This little gem could run up fast, they obviously have their science going in the right direction as the offers are there just not the price, could be a 10.00 offer in the works
👍️0
morokoy morokoy 1 week ago
Shares Outstanding 57,537,499 shares
Insider Shares 7,908,897 shares
Insider Ownership 13.75 %
Total Insiders 34
👍️0
morokoy morokoy 1 week ago
"The dividend distribution of rights will be payable to stockholders of record as of the close of business on April 29, 2024."

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends.

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends. You should receive a Form 1099-DIV, Dividends and Distributions from each payer for distributions of at least $10.

Guess we'll have to wait on the promised 8K.

Additional details of the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The filing will be available on the SEC's website at www.sec.gov.
👍️0
harry crumb harry crumb 1 week ago
Minimum 8$ imo
👍️0
MiamiGent MiamiGent 1 week ago
Vanda Pharmaceuticals rejects takeover proposal from Future Pak
REUTERS
1 mins ago
April 17 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.NaE) on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues the company.

(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
👍️0
Monksdream Monksdream 1 week ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️ 1
MiamiGent MiamiGent 1 week ago
Probably...but I took it at 5.49
👍️0
Monksdream Monksdream 1 week ago
Will it grow legs after 9:30
👍️0
MiamiGent MiamiGent 1 week ago
VNDA Vol picking up..

$5.49 +$1.44 (+35.56%)

Volume 3,354,569

90 DAV... 2M
👍️0
MiamiGent MiamiGent 1 week ago
VNDA Here we go
$5.3781 +$1.3281 (32.79%)

Bid ARCX
5.36 x 10
Ask XNMS
5.38 x 11
Volume
2,971,106
👍️0
MiamiGent MiamiGent 1 week ago
VNDA Vol is good. Already @ 90 DAV
Volume 2,056,421
10/90-day avg. volume
7M / 2M
👍️0
MiamiGent MiamiGent 1 week ago
VNDA Good post, Laster.
https://www.futurepak.com/
👍️0
Laster Laster 1 week ago
The major question is who is Future Pak really?
Is this a legit offer?
Either way, company is extremely undervalued with no debt (I believe) and lots of cash.
Large short position. Lots of selling PM at $5.
Market does not seem to believe this offer. Sorry.
👍️0
MiamiGent MiamiGent 1 week ago
VNDA Float 52.05M

Shares Short (3/28/2024) 2.49M
Short Ratio (3/28/2024) 2.78
Short % of Float (3/28/2024) 5.45%
👍️0
MiamiGent MiamiGent 1 week ago
VNDA
Bid EDGX
4.85 x 3
Ask EDGX
4.88 x 3

Volume
1,790,654
Avg Vol (10 day) 6.63M
👍️0
MiamiGent MiamiGent 1 week ago
Vanda Pharmaceuticals
Closed .01 (-0.25%)

Pre-market
$5.15 +1.10 (+27.16%)
As of Apr-17-2024 7:23:52 AM ET
Bid x size $5.14 x 1
Ask x size $5.16 x 3
👍️0
MiamiGent MiamiGent 1 week ago
VNDA In 5.12. Let's see, said the blind man.
👍️0
MiamiGent MiamiGent 1 week ago
Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
Apr. 17, 2024 6:41 AM ETVanda Pharmaceuticals Inc. (VNDA) Stock
👍️0
MiamiGent MiamiGent 1 week ago
What's the news?
👍️0
Awl416 Awl416 1 week ago
Damn
👍️0
Monksdream Monksdream 1 week ago
Will it grow legs after 9:30
👍️0
Monksdream Monksdream 3 weeks ago
Will it grow legs after 9:30
👍️0
tknuncle tknuncle 3 months ago
I have been acquiring since $3.90. I wish that I would have waited longer lol but, like what I see with VNDA. Was going to grab the last of my starter position soon. GLTA
👍️0
weedtrader420 weedtrader420 3 months ago
FDA Approve
👍️0
Triple nickle Triple nickle 5 months ago
Fda accepts new drug application for tradipitant in the after hours today
👍️ 1
jgrabar jgrabar 2 years ago
$VNDA -On May 19, 2022, Vanda Pharmaceuticals agreed to settle a securities fraud class action complaint (the “Complaint”) for $11.5 Million. https://grabarlaw.com/the-latest/vanda-pharmaceuticals-investigation/
👍️0
RNsidersbuying RNsidersbuying 3 years ago
VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen
👍️0
XenaLives XenaLives 4 years ago
Everything would be a lot better if the govt. would just let doctors treat COVID like another flu bug. The drama is getting old.
👍️0
Peepson Peepson 4 years ago
Yo, this thing is going to trade sideways for a while. They have a drug that could help with covid but so does every other pharma company. Its a safe hold imo but nothing will happen fast i don't think
👍️0
XenaLives XenaLives 4 years ago
What's up? Doesn't seem to be much interest. I was looking at the chart but haven't found much on the company yet.

👍️0
otcmoneydoubler otcmoneydoubler 4 years ago
LOL. VNDA GOT NEWS TODAY. SO WHAT DD HAVE YOU GOT TO SHARE?
👍️0
Peepson Peepson 4 years ago
Yo, does anyone still follow this board. I might have some interesting dd to share.
👍️0
bezen bezen 7 years ago
https://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html
👍️0
Coz Mabluda Coz Mabluda 7 years ago
Brett Jensen. SA article re VNDA. Expects positive analyst's review.

Vanda Pharmaceuticals (NASDAQ:VNDA) posted solid third quarter results on Thursday. Instead of losing a dime a share as expected, the company posted a profit of 11 cents a share. Revenue was also up more than 35% from the same period a year ago. The company now looks like it could be profitable in FY2017. I expect some positive analyst commentary on this name by analysts over the next week. Vanda has a solid pipeline and over $140 million in cash and marketable securities on the balance sheet. One has to like the company's growth trajectory and the concern seems undervalued with just a $600 million market capitalization.



👍️0
stocktrademan stocktrademan 8 years ago
fast and steady profit scan VNDA bullish 16.64



normal chart


log chart

👍️0
ClearlyStocks ClearlyStocks 8 years ago
VNDA $16.74
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$VNDA $16 from $14 now
👍️0
nyctraydr nyctraydr 8 years ago
Where Things Stand For Vanda Pharmaceuticals In Fanapt Patent Suit http://marketexclusive.com/things-stand-vanda-pharmaceuticals-inc-nasdaqvnda-fanapt-patent-suit/24951/?icd1
👍️0
ClayTrader ClayTrader 8 years ago
* * $VNDA Video Chart 08-25-16 * *

Link to Video - click here to watch the technical chart video
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$15.24 weeee
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$14.60
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$14.22
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$14 wow
👍️0
GREEN MAKER GREEN MAKER 8 years ago
Approved!!!!!
👍️0
jaytea jaytea 8 years ago
VNDA PDUFA Friday:

The FDA has set a user fee goal date under the Prescription Drug User Fee Act of May 27, 2016, which is the target date for the FDA to complete its review of the sNDA.
👍️0
jaytea jaytea 8 years ago
VNDA breaks above 200 day MA
👍️0
jaytea jaytea 8 years ago
Moving up nicely this morning.
👍️0
Ppower Ppower 9 years ago
Nice been following this stock for awhile now and made some good money here.

Also, follow Titan Pharmaceuticals TTNP
👍️0

Your Recent History

Delayed Upgrade Clock